drugset / Trial / NCT00530257
Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory
Phase 4
Completed
30 enrolled
Children's Hospital of Philadelphia
Ortho-McNeil Janssen Scientific Affairs, LLC · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study investigates whether OROS-methylphenidate improves performance on different aspects of attention and memory in children with Attention-Deficit Hyperactivity Disorder (ADHD).
Timeline
- Start
- 2004-06
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Methylphenidate | Small molecule | 18 mg | — |
| Comparator | Methylphenidate | Small molecule | 54 mg | — |